JP TSE 4534 Pharmaceutical

Mochida Pharmaceutical Co.,Ltd.

持田製薬株式会社

Revenue

¥117B

≈ $740.4M

Net income

¥7.9B

≈ $50.0M

Income taxes paid

¥2.4B

≈ $14.9M

Total assets

¥183B

≈ $1.2B

Equity ratio

76.8%

Ranked #1,061 among listed Japanese companies by corporate taxes paid · effective tax rate 29.2%.

Share price at fiscal year-end: ¥3,456 · market capitalization ¥126B · P/E 15.5 · P/B 0.90

US dollar amounts use ¥158.0 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
Mar 2026	¥117B	¥7.9B	¥3.3B	¥2.4B	¥183B	¥140B	76.8%	EDINET (consol.)
Mar 2025	¥105B	¥5.7B	¥2.4B	¥948M	¥160B	¥131B	81.6%	EDINET (consol.)
Mar 2024	¥103B	¥4.5B	—	—	¥159B	¥128B	80.6%	EDINET (consol.)
Mar 2023	¥103B	¥6.6B	—	—	¥159B	¥127B	79.8%	EDINET (consol.)
Mar 2022	¥110B	¥10.6B	—	—	¥163B	¥129B	78.9%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.